Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Mims

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|June 12, 2024
Impact of chronic graft-<i>versus</i>-host disease on non-relapse mortality and survivalJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Leukemia & Lymphoma|November 24, 2020
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDSBrendan Rasor, Tyler Dickerson, Qiuhong Zhao, et al.
Journal of Geriatric Oncology|November 6, 2024
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancyAshley E Rosko, Ying Huang, Sarah A Wall, et al.
Blood Advances|August 30, 2023
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemiaFarhad Ravandi, Asad Bashey, James Foran, et al.
Cancers|November 26, 2022
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional ExperienceJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Journal of Hematology & Oncology|August 19, 2016
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryMichael M B Green, Nelson Chao, Saurabh Chhabra, et al.
Haematologica|May 19, 2018
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34<sup>+</sup>CD123<sup>+</sup> cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donorsRajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, et al.
Leukemia|May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 yearsAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
Blood Advances|February 23, 2018
Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor J Kovacsovics, Alice Mims, Mohamed E Salama, et al.
The AAPS Journal|November 27, 2012
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemiaHongyan Wang, Ping Chen, Jiang Wang, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|June 12, 2024
Impact of chronic graft-<i>versus</i>-host disease on non-relapse mortality and survivalJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Leukemia & Lymphoma|November 24, 2020
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDSBrendan Rasor, Tyler Dickerson, Qiuhong Zhao, et al.
Journal of Geriatric Oncology|November 6, 2024
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancyAshley E Rosko, Ying Huang, Sarah A Wall, et al.
Blood Advances|August 30, 2023
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemiaFarhad Ravandi, Asad Bashey, James Foran, et al.
Cancers|November 26, 2022
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional ExperienceJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Journal of Hematology & Oncology|August 19, 2016
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryMichael M B Green, Nelson Chao, Saurabh Chhabra, et al.
Haematologica|May 19, 2018
The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34<sup>+</sup>CD123<sup>+</sup> cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donorsRajeswaran Mani, Swagata Goswami, Bhavani Gopalakrishnan, et al.
Leukemia|May 29, 2020
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 yearsAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Alice Mims, et al.
Blood Advances|February 23, 2018
Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemiaTibor J Kovacsovics, Alice Mims, Mohamed E Salama, et al.
The AAPS Journal|November 27, 2012
In vivo quantification of active decitabine-triphosphate metabolite: a novel pharmacoanalytical endpoint for optimization of hypomethylating therapy in acute myeloid leukemiaHongyan Wang, Ping Chen, Jiang Wang, et al.
Pageof 5